Handa Pharmaceuticals, Inc. (TPEX:6620)
Taiwan · Delayed Price · Currency is TWD 125.50
+11.00 (9.61%)
Nov 10, 2026, 1:30 PM CST
Handa Pharmaceuticals Market Cap
Handa Pharmaceuticals has a market cap or net worth of 20.4 billion as of November 9, 2026. It is the 13,007th most valuable company in the world and the 404th biggest in Taiwan. Its market cap has increased by 5.72% in one year.
Market Cap
20.40B
Enterprise Value
16.71B
Revenue
1.21B
Global Rank
Country Rank
#404 Taiwan
PE Ratio
41.58
ChartMarket Cap Chart
Since December 28, 2016, Handa Pharmaceuticals's market cap has increased from 8.32B to 20.40B, an increase of 145.19%. That is a compound annual growth rate of 9.51%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 10, 2026 | 20.40B | 50.75% |
| Dec 31, 2025 | 13.53B | 27.93% |
| Dec 31, 2024 | 10.58B | -59.15% |
| Dec 29, 2023 | 25.89B | 61.07% |
| Dec 30, 2022 | 16.07B | 90.20% |
| Dec 30, 2021 | 8.45B | 199.72% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bora Pharmaceuticals | 50.85B |
| Lotus Pharmaceutical | 44.77B |
| Center Laboratories | 22.31B |
| TTY Biopharm Company | 19.69B |
| ScinoPharm Taiwan | 15.93B |
| YungShin Global Holding | 15.66B |
| Synmosa Biopharma | 14.72B |
| Grape King Bio | 11.93B |